New Website for Curasight
Curasight is a pioneer in exploiting a new Positron Emission Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (“uPAR”). The technology provides improved diagnosis and risk assessment in several cancers, especially for risk assessment in prostate cancer.
Here we startet with designing a new logo and brand for Curasight. Serious website with extra emphasis on media, smartphones, iPhones, tablets and iPads. Would you like to hear more, please call or email. We update, maintain and host this website.